These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6819938)

  • 1. [Variation of serum human growth hormone concentrations in various physiological and pathological conditions: a preliminary analysis of 441 cases].
    Zhang WR
    Zhonghua Nei Ke Za Zhi; 1982 Nov; 21(11):669-73. PubMed ID: 6819938
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abnormal reaction of GH to TRH and l-dopa stimulation in acromegaly].
    Haniu K; Taya T; Aida M; Yoshinaga K
    Horumon To Rinsho; 1976 Nov; 24(11):1145-50. PubMed ID: 827402
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
    [No Abstract]   [Full Text] [Related]  

  • 4. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly.
    Maeda K
    Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly.
    Giustina G; Reschini E; Peracchi M; Cantalamessa L; Cavagnini F; Pinto M; Bulgheroni P
    J Clin Endocrinol Metab; 1974 May; 38(5):906-9. PubMed ID: 4207370
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormonal evaluation of 27 patients with acromegaly].
    Villabona C; Novials A; Soler J; Morató J; Gómez JM; Navarro MA
    Med Clin (Barc); 1985 Feb; 84(6):219-22. PubMed ID: 3920452
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of TRF, propranolol-glucagon, insulin and glucose stimulation tests in acromegaly.
    Coutant G; Vandeweghe M; Vermeulen A
    Horm Metab Res; 1977 Jan; 9(1):17-21. PubMed ID: 403115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spontaneous diurnal variations as well as the effect of TRH, MIH and LH-RH on growth hormone secretion in active acromegaly].
    Heesen D; Hadam W; Mies R; Schorn H; Winkelmann W
    Verh Dtsch Ges Inn Med; 1975; 81():1521-3. PubMed ID: 5831
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type].
    Fujita M; Toyoda K; Motomura N; Kuroda K; Shimizu T
    Rinsho Shinkeigaku; 1985 Jul; 25(7):767-75. PubMed ID: 3935351
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
    Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
    J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Further findings on the action of synthetic thyrotropin releasing hormone on the TSH serum level in various endocrine diseases].
    Wagner H; Böckel K; Grote G; Hrubesch M; Vosberg H; Junge-Hülsing G; Hauss WH
    Med Welt; 1972 Oct; 23(41):1419-21. PubMed ID: 4628828
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 14. The assay and regulation of prolactin in humans.
    Frantz AG
    Adv Exp Med Biol; 1977; 80():95-133. PubMed ID: 197813
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to synthetic thyrotropin releasing hormone in man. Preliminary report.
    Polosa P; Vigneri R; Papalia D; Squatrito S; Motta L
    J Nucl Biol Med; 1971; 15(3):95-7. PubMed ID: 4111540
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of growth hormone and prolactin secretion in patients with acromegaly and-or excessive prolactin secretion.
    Cryer PE; Jacobs LS; Daughaday WH
    Mt Sinai J Med; 1973; 40(3):402-13. PubMed ID: 4197309
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone in the blood of patients after administration of synthetic thyrotropin releasing hormone.
    Nedvídková J; Felt VI
    Vnitr Lek; 1976 May; 22(5):453-6. PubMed ID: 820068
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of thyroliberin (TRH), bromocriptine and cyproheptadine on somatotropin secretion in acromegaly.
    Pawlikowski M; Strejczek H; Owczarczyk I; Komorowski J
    Mater Med Pol; 1980; 12(1-2):70-3. PubMed ID: 6799708
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.